Related Experiment Videos
[Proliferative diabetic retinopathy and pregnancy]
Klinische Monatsblatter Fur Augenheilkunde
|September 1, 1982
Summary
Diabetic retinopathy in pregnant patients can be safely managed with laser coagulation. This treatment preserves or improves vision, making therapeutic abortion unnecessary for these individuals.
Area of Science:
- Ophthalmology
- Diabetology
- Reproductive Medicine
Context:
- Diabetic retinopathy (DR) is a significant complication of diabetes mellitus.
- Proliferative diabetic retinopathy (PDR) poses a risk to vision, especially during pregnancy.
- The management of PDR in pregnant patients has historically raised concerns regarding fetal and maternal outcomes.
Purpose:
- To evaluate the safety and efficacy of laser coagulation treatment for proliferative diabetic retinopathy in pregnant women.
- To assess the impact of coagulation treatment timing (before vs. during pregnancy) on visual outcomes.
- To determine if therapeutic abortion is still indicated for pregnant diabetics with PDR.
Summary:
- Thirty-seven eyes of twenty pregnant women with PDR were analyzed.
- Eighteen eyes received coagulation during pregnancy, and 14 were treated before pregnancy.
- Fundus morphology remained stable or improved in 31 eyes by the end of pregnancy, with best outcomes in those pre-treated.
Impact:
- Laser coagulation is a viable and effective treatment for PDR in pregnant diabetics.
- The findings challenge the necessity of therapeutic abortion solely based on the presence of PDR.
- Ophthalmological management can ensure favorable visual outcomes for pregnant women with PDR.